Oocyte Activation: Revised or Initial AGT Technique, Which is Better?! A Sibling-oocytes-split Design
NCT ID: NCT05113238
Last Updated: 2022-09-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
222 participants
INTERVENTIONAL
2021-10-15
2021-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
sample group : AGT-revised protocol oocytes will be injected by sperm previously cultured in Ca ionophore and 0.4 pL of calcium ionophore then will be cultured in calcium ionophore after injection for 10 minutes
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sperm Micro-swim up Technique; Process and Select in the Same Dish: a Sibling-oocyte-split Design
NCT05113225
Evaluating the Utility of Implementing Microfluids for Sperm Preparation Compared to Conventional Method of Density Gradient Centrifugation in a PGT-A Program: a Sibling Oocyte Study
NCT07093619
Comparison of Blood Flow in the Arteriae Uterinae in Ovarian Stimulation Cycles
NCT03887728
Effect of Different Sperm Processing Methods in ICSI Outcome.
NCT03668106
Time Lag for Oocyte Denudation: A Better Choice for ICSI Outcome?!
NCT04185623
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
For the AGT-revised protocol, ejaculated spermatozoa will be exposed to calcium ionophore in a drop on the ICSI dish before injection. During the ICSI procedure, spermatozoa will be aspirated individually from the drop containing calcium ionophore and immobilized in a separate polyvinylpyrrolidone drop. Next, approximately 0.4 pL of calcium ionophore will be aspirated into the micropipette and will be injected into the oocyte with the spermatozoa. Post-ICSI oocytes will be then exposed to 50 mM calcium ionophore for 10 minutes at 37 C, and then will be washed and placed in culture medium.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AGT-Initial
Oocytes will be injected with spermatozoa and will be incubated in 10 mM calcium ionophore (Sigma-Aldrich) for two rounds of 10 minutes at 37 C, 30 minutes after ICSI injection, and then will be rinsed and transferred into culture medium.
Assisted gamete activation
compare two different assisted gamete activation protocols to improve ICSI outcome
AGT-revised
ejaculated spermatozoa will be exposed to calcium ionophore in a drop on the ICSI dish before injection. During the ICSI procedure, spermatozoa will be aspirated individually from the drop containing calcium ionophore and immobilized in a separate PVP drop. Next, approximately 0.4 pL of calcium ionophore will be aspirated into the micropipette and injected into the oocyte with the spermatozoa.
Post-ICSI oocytes will be then exposed to 50 mM calcium ionophore for 10 minutes at 37C, and then will be washed and placed in culture medium.
Assisted gamete activation
compare two different assisted gamete activation protocols to improve ICSI outcome
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Assisted gamete activation
compare two different assisted gamete activation protocols to improve ICSI outcome
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* couples with previous complete fertilization failure after undergoing ICSI cycles
* At least 4 MII oocytes
* Severe oligoasthinozoospermia
* Teratozoospermia
* testicular aspirated sperm
Exclusion Criteria
* BMI \>34
* aspirated oocytes \< 4
* Normozoospermia
* subfertile patients
18 Years
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hawaa Fertility Center
OTHER
Royal Fertility Center, Egypt
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sahar SA Eissa, PHD
Role: STUDY_DIRECTOR
research team leader
Engy EA Abdallah, M.sc
Role: STUDY_CHAIR
investigator & researcher
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Royal Fertility Center
Al Mansurah, Daqahlya, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.